Issue №6-22, 2023

Review

https://doi.org/10.38025/2078-1962-2023-22-6-91-99

Osteoporotic Vertebral Compression Fractures: Medical, Social Aspects, Clinical Picture, Treatment and Medical Rehabilitation. A Review

View article (Download PDF file)



Download XML file

1 ORCIDLarisa A. Marchenkova

1National Medical Research Center for Rehabilitation and Balneology


ABSTRACT

INTRODUCTION. Osteoporosis is one of the most common metabolic skeletal diseases in the world, which is characterized by a decrease in bone tissue strength and an increased risk of fractures with minimal trauma, including pathological vertebral compression fractures (VCFs). VCFs are accompanied by a decrease in the quality of life of patients with osteoporosis due to a pronounced pain syndrome, sleep problems, decreased motor and social activity, a high risk of falls and fractures, the development of pathological spinal deformities, decreased lung capacity and increased number of comorbid diseases. In this regard, timely treatment and medical rehabilitation in patients with osteoporosis and VCFs are of particular importance to restore functionality, reduce the risk of developing new fractures, disability and death.

MAIN CONTENT OF THE REVIEW. The literature review is the analysis of 7 domestic and 49 foreign literary sources, which was used to describe the prevalence, medical and social significance and clinical picture of osteoporotic VCFs. It provides data on modern methods of drug and non-drug treatment of patients with VCFs. The effectiveness and limitations of the use of physical therapy methods in the rehabilitation of patients with pathological spinal fractures are described in detail.

CONCLUSION. It is concluded that VCFs pose a significant healthcare burden due to their high prevalence and negative impact on the quality of life of older patients with osteoporosis. Osteoporotic VCFs lead to the development of severe back pain, limited mobility, spinal deformities, loss of height and permanent disability. An effective strategy for the treatment and rehabilitation of patients with osteoporotic VCFs should include the use analgesics, orthotics, correction of nutritional deficiency, elimination of vitamin D and calcium deficiency, modern methods of physical therapy, fall prevention and timely prescription of effective drugs for pathogenetic therapy of osteoporosis to reduce the risk of pathological fractures in the future and ensure a high level of functioning and of the quality of life.


KEYWORDS: osteoporosis, vertebral compression fracture, pathological fracture, bisphosphonates, ibandronic acid, bone mineral density, treatment adherence, medical rehabilitation

Acknowledgments: The study had no sponsorship.

Conflict of interest:: The authors declare no apparent or potential conflicts of interest related to the publication of this article.

For citation: Marchenkova L.А. Osteoporotic Vertebral Compression Fractures: Medical, Social Aspects, Clinical Picture, Treatment and Medical Rehabilitation. A Review. Bulletin of Rehabilitation Medicine. 2023; 22(6): 91-99. https://doi.org/10.38025/2078-1962-2023-22-6-91-99 (In Russ.).

Для корреспонденции:  Larisa A. Marchenkova, E-mail: marchenkovala@nmicrk.ru



Список литературы:

  1. Pisani P., Renna M.D., Conversano F. et al. Major osteoporotic fragility fractures: Risk factor updates and societal impact. World Journal of Orthopaedics. 2016; 7(3): 171–181. https://doi.org/10.5312/wjo.v7.i3.171
  2. Griffith J.F. Identifying osteoporotic vertebral fracture. Quantitative Imaging in Medicine and Surgery. 2015; 5(4): 4292–4292. https://doi.org/10.3978/j.issn.2223-4292.2015.08.01
  3. Kamimura M., Nakamura Y., Sugino N. et al. Associations of self-reported height loss and kyphosis with vertebral fractures in Japanese women 60 years and older: a cross-sectional survey. Scientific Reports. 2016; 6: 29199–29199. https://doi.org/10.1038/srep29199
  4. Lewiecki E.M., Jaster A.J. Clinical review: Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry. The Journal of Clinical Endocrinology and Metabolism. 2006; 91(11): 4215–4222. https://doi.org/10.1210/jc.2006-1178
  5. Malgo F., Hamdy N.A.T., Ticheler C.H.J.M. et al. Value and potential limitations of vertebral fracture assessment (VFA) compared to conventional spine radiography: experience from a fracture liaison service (FLS) and a meta-analysis. Osteoporosis International. 2017; 28(10): 2955–2965. https://doi.org/10.1007/s00198-017-4137-6
  6. Dionissiotis Y. Management of osteoporotic vertebral fractures. International Journal of General Medicine. 2010; 3: 167–171. https://doi.org/10.2147/ijgm.s11751
  7. Jager P.L., Jonkman S., Koolhaas W. et al. Combined vertebral fracture assessment and bone mineral density measurement: a new standard in the diagnosis of osteoporosis in academic populations. Osteoporosis International. 2011; 22(4): 1059–1068. https://doi.org/10.1007/s00198-010-1293-3
  8. Ong T., Kantachuvesiri P., Sahota O., Gladman J.RF. Characteristics and outcomes of hospitalised patients with vertebral fragility fractures: a systematic review. Age and Ageing. 2018; 47(1): 17–25. https://doi.org/10.1093/ageing/afx079
  9. Li Y., Yan L., Cai S. et al. The prevalence and under-diagnosis of vertebral fractures on chest radiograph.BMC Musculoskeletal Disorders. 2018; 19(1): 235–235. https://doi.org/10.1186/s12891-018-2171-y
  10. Papaioannou A., Kennedy C.C., Ioannidis G.et al. The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian multicentre osteoporosis study. Osteoporosis International. 2009; 20(5): 703–714. https://doi.org/10.1007/s00198-008-0743-7
  11. Guillemin F., Martinez L., Calvert M. et al. Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study. Osteoporosis International. 2013; 24(12): 3001–3010. https://doi.org/10.1007/s00198-013-2408-4
  12. Lips P., van Schoor N.M. Quality of life in patients with osteoporosis. Osteoporosis International. 2005; 16(5): 447–455. https://doi. org/10.1007/s00198-004-1762-7
  13. Peasgood T., Hermann K., Kanis J.A., Brazier J.E. An updated systematic review of Health State Utility Values for osteoporosis related conditions. Osteoporosis International. 2009; 20(6): 853–868. https://doi. org/10.1007/s00198-009-0844-y
  14. Thompson D.R., Yu C.-M. Quality of life in patients with coronary heart disease-I: assessment tools. Health and Quality of Life Outcomes. 2003; 1: 42. https://doi.org/10.1186/1477-7525-1-42
  15. Waterloo S., Søgaard A.J., Ahmed L.A. et al. Vertebral fractures and self-perceived health in elderly women and men in a population-based cross-sectional study: the Troms Study 2007-08. BMC Geriatrics. 2013; 13: 102. https://doi.org/10.1186/1471-2318-13-102
  16. Salaffi F., Cimmino M.A., Malavolta N. et al. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. The Journal of Rheumatology. 2007; 34(7): 1551–1560.
  17. El Maghraoui A., Mounach A., Rezqi A. et al . Vertebral fracture assessment in asymptomatic men and its impact on management. Bone. 2012; 50(4): 853–857. https://doi.org/10.1016/j.bone.2011.12.018
  18. Gokce Kutsal Y., Ozdemir O., Karahan S. et al. Musculoskeletal pain in osteoporotic elderly patients: a multicenter study. Turkish Journal of Physical Medicine and Rehabilitation. 2012; 58: 263–266.
  19. Марченкова Л.А., Фесюн А.Д., Герасименко М.Ю. Исследование выраженности психоэмоциональных нарушений у пациентов с остеопорозными переломами позвонков и влияющих на них факторов. Вопросы курортологии, физиотерапии и лечебной физической культуры. 2021. 98(3): 18–28. https://doi.org/10.17116/kurort20219803118 [Marchenkova L.A., Fesyun A.D., Gerasimenko M.Yu. Study of the severity of psycho-emotional disorders in patients with osteoporotic vertebral fractures and factors affecting them. Problems of balneology, physiotherapy, and exercise therapy. 2021; 98(3): 18–28. https://doi.org/10.17116/kurort20219803118 (In Russ.).]
  20. Марченкова Л.А., Макарова Е.В., Ерёмушкин М.А. и др. Оценка функциональных способностей пациентов с переломами позвонков на фоне остеопороза как основа для формирования реабилитационных программ. Физиотерапия, бальнеология и реабилитация. 2020. 19(3): 152–159. https://doi.org/10.17816/1681-3456-2020-19-3-3 [Marchenkova L.A., Makarova E.V., Eryomushkin M.A. et al. The evaluation of functional abilities of patients with osteoporotic vertebral fractures as a basis for rehabilitation programs developing. Russian journal of physiotherapy, balneology and rehabilitation. 2020. 19(3): 152–159. https://doi.org/10.17816/1681-3456-2020-19-3-3 (In Russ.).]
  21. Kutsal F.I., Ergin Ergani G.O. Vertebral compression fractures: Still an unpredictable aspect of osteoporosis. Turk J Med Sci. 2021; 51(2): 393–399. https://doi.org/10.3906/sag-2005-315
  22. Kanis J.A., Harvey N.C., McCloskey E. et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporosis International. 2020; 31(1): 1–12. https://doi.org/10.1007/s00198-019-05176-3
  23. Белая Ж.Е., Белова К.Ю., Бирюкова Е.В. и др. Федеральные клинические рекомендации по диагностике, лечению и профилактике остеопороза. Остеопороз и остеопатии. 2021; 24(2): 4–47. https://doi.org/10.14341/osteo12930 [Belaya Z.E., Belova K.Yu., Biryukova E.V. et al. Federal clinical guidelines for diagnosis, treatment and prevention of osteoporosis. Osteoporosis and bone diseases. 2021; 24(2): 4–47. https://doi.org/10.14341/osteo12930 (In Russ.).]
  24. Belaya Z., Rozhinskaya L., Dedov I. et al. A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis. Osteoporosis International. 2023; 34(3): 429–447. https://doi.org/10.1007/s00198-022-06667-6
  25. Eastell R., Rosen C.J., Black D.M. et al. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinololgy and Metabolism. 2019; 10(5)4: 1595–1622. https://doi.org/10.1210/jc.2019-00221
  26. Conley R.B., Adib G., Adler R.A. et al. Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition. Journal of Orthopadic Trauma. 2020; 35(1): 36–52. http://dx.doi.org/10.1097/BOT.0000000000001743
  27. Мазуров В.И., Лесняк О.М., Белова К.Ю. и др. Алгоритмы выбора терапии остеопороза при оказании первичной медико-санитарной помощи и организации льготного лекарственного обеспечения отдельных категорий граждан, имеющих право на получение государственной социальной помощи. Системный обзор и резолюция Экспертного совета Российской ассоциации по остеопорозу. Профилактическая медицина. 2019; 22(1): 57–65. https://doi.org/10.17116/profmed20192201157 [Mazurov V.I., Lesnyak O.M., Belova K.Yu. et al. Algorithm for selection of drug for osteoporosis treatment in primary care and in organization of provision with medicinal products of citizens eligible for state social assistance. Review of the literature and position of Russian Association on Osteoporosis Expert Council. The Russian Journal of Preventive Medicine. 2019; 22(1): 57–65. https://doi.org/10.17116/profmed20192201157 (In Russ.).]
  28. Kim S.-R., Ha Y.-C., Park Y.-G. et al. Orthopedic surgeon’s awareness can improve osteoporosis treatment following hip fracture: a prospective cohort study. Journal of Korean Medical Science. 2011; 26(11): 1501–1507. https://doi.org/10.3346/jkms.2011.26.11.1501
  29. Chesnut C.H., III, Skag A., Christiansen C. et al. Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. Journal of Bone and Mineral Reseach. 2004; 19(8): 1241–1249. https://doi.org/10.1359/jbmr.040325
  30. Simonelli C., Burke M.S. Less frequent dosing of bisphosphonates in osteoporosis: focus on ibandronate. Current Medical Research and Opinion. 2006; 22(6): 1101–8. https://doi.org/10.1185/030079906x104867
  31. Bauss F., Schimmer R.C. Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis. Therapeutics and Clinical Risk Management. 2006; 2(1): 3–18.
  32. Miller P.D., Recker R.R., Reginster J.Y. et al. Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study. Osteoporosis Internation. 2012; 23(6): 1747–1756. https://doi.org/10.1007/s00198-011-1773-0
  33. Miller P.D., Epstein S., Sedarati F., Reginster J.Y. Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study. Curr Med Res Opin. 2008; 24(1): 207–213. https://doi.org/10.1185/030079908x253889
  34. Harris S.T., Blumentals W.A., Miller PD. Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies. Current Medical Research and Opinion. 2008; 24(1): 237–245. https://doi.org/10.1185/030079908x253717
  35. Harris S.T., Reginster J.Y., Harley C. et al. Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: the eValuation of IBandronate Efficacy (VIBE) database fracture study. Bone. 2009; 44(5): 758–765. https://doi.org/10.1016/j.bone.2009.01.002
  36. Cooper A., Drake J., Brankin E., PERSIST Investigators. Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study. International Journal of Clinical Practice. 2006; 60(8): 896–905. https://doi.org/10.1111/j.1742-1241.2006.01059.x
  37. Emkey R., Koltun W.,Beusterien K. et al. Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO). Current in Medical Research and Opinion. 2005; 21(12): 1895–903. https://doi.org/10.1185/030079905X74862
  38. Nuti R., Brandi M.L., Checchia G. et al. Guidelines for the management of osteoporosis and fragility fractures. Internal and Emergency Medicine. 2019; 14(1): 85–102. https://doi.org/10.1007/s11739-018-1874-2
  39. Hirsch J.A., Beall D.P., Chambers M.R. et al. Management of vertebral fragility fractures: a clinical care pathway developed by a multispecialty panel using the RAND/UCLA appropriateness method. The Spine Journal. 2018; 18(11): 2152–2161. https://doi.org/10.1016/j.spinee.2018.07.025
  40. Longo U.G., Loppini M., Denaro L. et al. Conservative management of patients with an osteoporotic vertebral fracture: a review of the literature. The Journal of Bone and Joint Surgery. 2012; 94(2): 152–157. https://doi.org/10.1302/0301-620X.94B2.26894
  41. Baethge C., Goldbeck-Wood S., Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Research Integrity and Peer Review. 2019; 4: 5. https://doi.org/10.1186/s41073-019-0064-8
  42. Pinto D., Alshahrani M., Chapurlat R. et al. The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors. Osteoporosis International. 2022; 33: 527–540. https://doi.org/10.1007/s00198-021-06240-7
  43. Pegrum J., Crisp T., Padhiar N., Flynn J. The pathophysiology, diagnosis, and management of stress fractures in postmenopausal women. The Physican and Sportsmedicine. 2012; 40(3): 32–42. https://doi.org/10.3810/psm.2012.09.1978
  44. Giangregorio L.M., Macintyre N.J., Thabane L. Exercise for improving outcomes after osteoporotic vertebral fracture. The Cochrane Database of Systematic Reviews. 2013; 1: https://doi.org/10.1002/14651858.cd008618.pub2
  45. Stanghelle B., Bentzen H., Giangregorio L. et al. Effects of a resistance and balance exercise programme on physical fitness, health-related quality of life and fear of falling in older women with osteoporosis and vertebral fracture: a randomized controlled trial. Osteoporosis International. 2020; 31(6): 1069–1078. https://doi.org/10.1007/s00198-019-05256-4
  46. Stanghelle B., Bentzen H., Giangregorio L. et al. Physical fitness in older women with osteoporosis and vertebral fracture after a resistance and balance exercise programme: 3-month post-intervention follow-up of a randomised controlled trial. BMC Musculoskeletal Disorders. 2020; 21(1): 471. https://doi.org/10.1186/s12891-020-03495-9
  47. Cergel Y., Topuz O., Alkan H. et al. The effects of short-term back extensor strength training in postmenopausal osteoporotic women with vertebral fractures: comparison of supervised and home exercise program. Archives Osteoporosis. 2019; 14(1): 82. https://doi.org/10.1007/s11657-019-0632-z
  48. Watson S.L., Weeks B.K., Weis L.J. et al. High-Intensity resistance and impact training improves bone mineral density and physical function in postmenopausal women with osteopenia and osteoporosis: the LIFTMOR randomized controlled trial. Journal of Bone and Mineral Research. 2018; 33(2): 211–220. https://doi.org/10.1002/jbmr.3284
  49. Марченкова Л.А., Макарова Е.В., Герасименко М.Ю. и др. Эффективность нового комплекса физической реабилитации с включением технологий механотерапии в улучшении показателей качества жизни пациентов с компрессионными переломами позвонков на фоне остеопороза. Физиотерапия, бальнеология и реабилитация. 2020; 19(1): 51–58. https://doi.org/10.17816/1681-3456-2020-19-1-8 [Marchenkova L.A., Makarova E.V., Gerasimenko M.Yu. et al. The effectiveness of a new complex of physical rehabilitation with the inclusion of mechanotherapy technologies in improving quality of life in patients with osteoporotic vertebral fractures. Russian Journal of the Physial Therapy, Balneotherapy and Rehabilitation. 2020; 19(1): 51–58. https://doi.org/10.17816/1681-3456-2020-19-1-8 (In Russ.).]
  50. Thomas S., Mackintosh S., Halbert J. Determining current physical therapist management of hip fracture in an acute care hospital and physical therapists’ rationale for this management. Physical Therapy & Rehabilitation Journal. 2011; 91(10): 1490–1502. https://doi.org/10.2522/ptj.20100310
  51. Mangione K.K., Lopopolo R.B., Neff N.P. et al. Interventions used by physical therapists in home care for people after hip fracture. Physical Therapy & Rehabilitation Journal. 2008; 88(2): 199–210. https://doi.org/10.2522/ptj.20070023
  52. Bennell K.L., Matthews B., Greig A. et al. Effects of an exercise and manual therapy program on physical impairments, function and quality-of-life in people with osteoporotic vertebral fracture: a randomised, single-blind controlled pilot trial. BMC Musculoskeletal Disorders. 2010; 11: 36. https://doi.org/10.1186/1471-2474-11-36
  53. Barker K.L., Newman M., Stallard N. et al. Physiotherapy rehabilitation for osteoporotic vertebral fracture-a randomised controlled trial and economic evaluation (PROVE trial). Osteoporos Int. 2020; 31(2): 277–289. https://doi.org/10.1007/s00198-019-05133-0
  54. Shibasaki K., Asahi T., Kuribayashi M. et al. Potential prescribing omissions of anti-osteoporosis drugs is associated with rehabilitation outcomes after fragility fracture: Retrospective cohort study. Geriatrics and Gerontology International. 2021; 21(5): 386–391. https://doi.org/10.1111/ggi.14145
  55. Марченкова Л.А., Макарова Е.В., Васильева В.А. и др. Влияние базовой терапии кальцием и витаминами D3 и В6 на мышечную силу, функции движения и баланса у пациентов с остеопорозом, проходивших медицинскую реабилитацию. Вопросы курортологии, физиотерапии и лечебной физической культуры. 2020; 97(1): 25–34. https://doi.org/10.17116/kurort20209701125 [Marchenkova L.A., Makarova E.V., Vasilieva V.A. et al. The effect of basic therapy with calcium and vitamins D3 and В6 on muscle strength, movement and balance functions at patients with osteoporosis undergoing medical rehabilitation. Problems of balneology, physiotherapy, and exercise therapy. 2020; 97(1): 25–34. https://doi.org/10.17116/kurort20209701125 (In Russ.).]
  56. Марченкова Л.А., Фесюн А.Д., Герасименко М.Ю., Макарова Е.В. Влияние приема биологически активной добавки к пище с кальцием и витаминами D3 и B6 на показатели кальциевого гомеостаза и частоту падений у проходящих медицинскую реабилитацию пациентов с высоким риском переломов. Вопросы питания. 2020; 89(5): 89–100. https://doi.org/10.24411/0042-8833-2020-10069 [Marchenkova L.A., Fesyun A.D., Gerasimenko M.Yu., Makarova E.V. The effect of administration of dietary supplement with calcium and vitamins D3 and B6 on calcium homeostasis and falls incidence in patients with high fracture risk undergoing medical rehabilitation. Voprosy pitaniia [Problems of Nutrition]. 2020; 89(5): 89–100. https://doi.org/10.24411/0042-8833-2020-10069 (In Russ.).]



Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©

Эта статья открытого доступа по лицензии CC BY 4.0. Издательство: ФГБУ «НМИЦ РК» Минздрава России.
This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.